Skip to content

Comparison between oral and IV infusion of magnesium on arrhythmia and hypomagnesemia after heart surgery

The Comparison between oral magnesium supplement before surgery and IV administration of magnesium during induction in prevention of hypomagnesemia and arrhythmia after coronary surgery in hospitals related to Shiraz University of Medical sciences

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015052122359N1
Enrollment
86
Registered
2015-11-11
Start date
2015-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Arrhythmia. Condition 2: hypomagnesemia. Ischaemic heart diseases Other disorders of electrolyte and fluid balance, not elsewhere classified

Interventions

Intervention 1: Mg-so4 20% was given to the 43 patients in control group after anesthesia induction. Then during CPB, before rewarming take the blood sample and after opening cross clamp . 2gr Mgso
Treatment - Drugs
Mg-so4 20% was given to the 43 patients in control group after anesthesia induction. Then during CPB, before rewarming take the blood sample and after opening cross clamp . 2gr Mgso4 inserted to th
20-30cc Mg- Hydroxide15% was given to the intervention group with NGT after anesthesia induction. Then during CPB, before rewarming take the blood sample and after opening cross clamp . 2gr Mgso4 20%

Sponsors

Vice chancellor for research,Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:All patients who are candidates for Coronary Artery Bypass Grafts in Shiraz University of Medical Sciences hospitals without Renal Failure, liver failure,no B- blocker or Ca- blocker preoperatively cause of arrhythmia, no preoperative Magnesium therapy . Exclusion criteria: Re-operation after main surgery because of hemorrhage, IABP usage .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum magnesium level. Timepoint: pre operation,during cardiopulmonary bypass and 6,12,24,48 hours after CABG. Method of measurement: Serum Magnesium has been tested with dirui-cs800 set and with xylidyl blue test.;Heart rhythm. Timepoint: 48 hours after CABG. Method of measurement: Heart monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJanati Mansor

Shiraz University of Medical Sciences

janatim@sums.ac.ir+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026